DUBLIN, Jan. 22, 2024 /PRNewswire/ -- The 'U.S. Contrast Media Market Size, Share & Trends Analysis Report by Modality (Modality, Ultrasound, Magnetic Resonance Imaging (MRI), X-ray/Computed Tomography (CT Scan)), Type, Application, and Segment Forecasts, 2023-2030' report has been added to ResearchAndMarkets.com's offering..

都柏林，2024年1月22日。S、 对比剂市场规模、份额和趋势分析报告（模态、超声波、磁共振成像（MRI）、X射线/计算机断层扫描（CT扫描））、类型、应用和细分市场预测，2023-2030年的报告已添加到ResearchAndMarkets.com的产品中。。

The U.S. contrast media market size is expected to reach USD 3.36 billion by 2030, registering a CAGR of 4.1% from 2023 to 2030

到2030年，美国造影剂市场规模预计将达到33.6亿美元，2023年至2030年的复合年增长率为4.1%

The increasing burden of chronic diseases is creating a demand for diagnostic imaging procedures, which, in turn, is driving the market growth. Imaging tests, such as MRI, have become an integral part of the diagnosis for most diseases, and large-scale penetration of imaging technology in healthcare has increased the demand for contrast media in the U.S.

慢性病的负担越来越重，对诊断成像程序产生了需求，这反过来又推动了市场的增长。MRI等成像测试已成为大多数疾病诊断的组成部分，成像技术在医疗保健中的大规模渗透增加了美国对造影剂的需求。

market..

市场。。

Chronic diseases, such as cancer and diabetes, are rapidly becoming a major public health concern and are among the leading causes of death across the U.S., resulting in the need for early diagnostic tools and effective treatment options.

癌症和糖尿病等慢性疾病正在迅速成为主要的公共卫生问题，并且是美国死亡的主要原因之一，因此需要早期诊断工具和有效的治疗选择。

Hence, the increasing prevalence of complex comorbidities and long-term diseases is one of the major drivers of imaging tests and contrast agents; thus, contributing to the market growth. The COVID-19 outbreak had a negative impact on the market due to decreased patient visits to hospitals. Many radiology departments experienced a rapid decline in imaging case volume..

因此，复杂合并症和长期疾病的患病率增加是影像学检查和造影剂的主要驱动因素之一；因此，有助于市场增长。新型冠状病毒肺炎的爆发对市场产生了负面影响，因为患者就诊次数减少。许多放射科的影像病例数量迅速下降。。

However, many states in the U.S. have begun to reopen their economies; however, it will take time for the utilization rate of contrast media to reach pre-pandemic levels. In addition, with the launch of COVID-19 vaccines and ease in restrictions, the import and export of raw materials have resumed. This, in turn, therefore, is expected to boost the market growth over the forecast period..

然而，美国许多州已经开始重新开放经济；然而，造影剂的利用率需要时间才能达到大流行前的水平。此外，随着新型冠状病毒肺炎疫苗的推出和限制的放宽，原材料的进出口已经恢复。因此，预计这将在预测期内推动市场增长。。

U.S. Contrast Media Market Report Highlights

U、 美国造影剂市场报告亮点

Imaging tests, such as MRI, have become an integral part of the diagnosis for most diseases, and large-scale penetration of imaging technology in healthcare has increased the demand for contrast media in the U.S. market

MRI等成像测试已成为大多数疾病诊断的组成部分，成像技术在医疗保健中的大规模渗透增加了美国市场对造影剂的需求

The iodinated contrast media dominated the market and held the largest market share of over 60% in 2022 on account of excellent radio-opacity and low toxicity of iodinated contrast media than other agents

碘造影剂在市场上占据主导地位，2022年占据了超过60%的最大市场份额，因为碘造影剂比其他药物具有优异的不透光性和低毒性

The X-ray/CT segment dominated the market and held the largest market share of around 65% in 2022. Wide acceptance and cost-efficiency of X-ray/CT modality boost the adoption of contrast agents for this modality

X射线/CT部门主导了市场，并在2022年占据了约65%的最大市场份额。X射线/CT模式的广泛接受和成本效益促进了造影剂在这种模式中的应用

The rising demand for imaging procedures has resulted in extensive R&D activities by contrast media manufacturers to launch novel products in the market and to get approved for new indications

对成像程序的需求不断增长，导致造影剂制造商进行了广泛的研发活动，以在市场上推出新产品并获得新适应症的批准

For instance, in 2021, Bracco got the U.S. FDA approval for 20-vial pack configuration of Lumason, which is an ultrasound contrast media agent

例如，2021年，Bracco获得了美国食品和药物管理局（FDA）对Lumason的20瓶包装配置的批准，Lumason是一种超声波造影剂

Company Profiles

公司简介

Bayer AG

拜耳公司

GE Healthcare

GE Healthcare

Guerbet

盖尔贝

Lantheus Medical Imaging, Inc

Lantheus医学影像公司

Bracco Diagnostic Inc

布拉科诊断公司

Trivitron Healthcare

Trivitron Healthcare

Nano Therapeutics Pvt Ltd.

Nano Therapeutics私人有限公司。

IMAX Diagnostic Imaging

IMAX诊断成像

CMC Contrast AB (ASCELIA PHARMA AB)

CMC Contrast AB（ASCELIA PHARMA AB）

Key Topics Covered: Chapter 1. Methodology and ScopeChapter 2. Executive Summary2.1. Market Outlook2.2. Segment Outlook2.3. Competitive InsightsChapter 3. U.S. Contrast Media Market Variables, Trends & Scope3.1. Market Lineage Outlook3.1.1. Parent market outlook3.1.2. Related/ancillary market outlook3.2.

涵盖的主要主题：第1章。方法和范围第2章。执行摘要2.1。市场展望2.2。分部展望2.3。竞争洞察力第3章。U、 美国造影剂市场变量、趋势和范围3.1。市场谱系展望3.1.1。母公司市场展望3.1.2。相关/辅助市场展望3.2。

Penetration & Growth Prospect Mapping3.3. Market Dynamics3.3.1. Market driver analysis3.3.2. Market restraint analysis3.4. U.S. Contrast Media Market Analysis Tools3.4.1. Industry Analysis - Porter's3.4.2. PESTEL AnalysisChapter 4. U.S. Contrast Media: Type Estimates & Trend Analysis4.1. U.S. Contrast Media Market, By Type Key Takeaways4.2.

渗透与增长前景图3.3。市场动态3.3.1。市场驱动因素分析3.3.2。市场约束分析3.4。U、 美国造影剂市场分析工具3.4.1。行业分析-波特的3.4.2。鼠疫分析第4章。U、 美国造影剂：类型估计和趋势分析4.1。U、 美国造影剂市场，按类型关键要点4.2。

U.S. Contrast Media Market: Movement & Market Share Analysis, 2022 & 20304.3. Microbubble Contrast Media4.4. Gadolinium-based Contrast Media4.5. Iodinated Contrast Media4.6. Barium-based Contrast MediaChapter 5. U.S. Contrast Media: Modality Estimates & Trend Analysis5.1. U.S. Contrast Media Market, By Modality Key Takeaways5.2.

U、 《美国造影剂市场：运动与市场份额分析》，2022和20304.3。微泡造影剂4.4。钆基造影剂4.5。碘化造影剂4.6。钡基造影剂第5章。U、 美国造影剂：模态估计和趋势分析5.1。U、 美国造影剂市场，按模态关键要点5.2。

U.S. Contrast Media Market: Movement & Market Share Analysis, 2022 & 20305.3. Ultrasound5.4. Magnetic Resonance Imaging (MRI)5.5. X-RAY/Computed Tomography (CT Scan)Chapter 6. U.S. Contrast Media: Application Estimates & Trend Analysis6.1. U.S. Contrast Media Market, By Application Key Takeaways6.2.

U、 《美国造影剂市场：运动与市场份额分析》，2022和20305.3。超声波5.4。磁共振成像（MRI）5.5。X射线/计算机断层扫描（CT扫描）第6章。U、 美国造影剂：应用评估和趋势分析6.1。U、 美国造影剂市场，按应用程序关键要点6.2。

U.S. Contrast Media Market: Movement & Market Share Analysis, 2022 & 20306.3. Cardiovascular6.4. Neurological Disorders6.5. Gastrointestinal Disorders6.6. Cancer6.7. Nephrological Disorders6.8. Musculoskeletal DisordersChapter 7. Competitive Landscape7.1. Recent Developments & Impact Analysis, By Key Market Participants7.2.

U、 《美国造影剂市场：运动与市场份额分析》，2022和20306.3。心血管6.4。神经系统疾病6.5。胃肠道疾病6.6。癌症6.7。肾病6.8。肌肉骨骼疾病Schapter 7。竞争性景观7.1。主要市场参与者的最新发展和影响分析7.2。

Company/Competition Categorization7.2.1. Company overview7.2.2. Financial performance7.2.3. Product benchmarking7.2.4. Strategic initiatives.

公司/竞争分类7.2.1。公司概述7.2.2。财务绩效7.2.3。产品基准7.2.4。战略举措。

For more information about this report visit https://www.researchandmarkets.com/r/yxc4qv

For more information about this report visithttps://www.researchandmarkets.com/r/yxc4qv

About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

关于ResearchAndMarkets.com ResearchAndMarkets.com是全球领先的国际市场研究报告和市场数据来源。我们为您提供有关国际和地区市场、关键行业、顶尖公司、新产品和最新趋势的最新数据。

Media Contact:Research and MarketsLaura Wood, Senior Manager[email protected]

媒体联系人：研究与市场高级经理Slaura Wood[受电子邮件保护]

For E.S.T Office Hours Call +1-917-300-0470For U.S./CAN Toll Free Call +1-800-526-8630For GMT Office Hours Call +353-1-416-8900

对于E.S.T办公时间，请拨打+1-917-300-0470（对于美国）/CAN免费电话+1-800-526-8630（对于GMT办公时间），请拨打+353-1-416-8900

U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716

U、 美国传真：646-607-1907传真（美国境外）：+353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

徽标：https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets

来源研究和市场